Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on June 1, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BPX Mines 90,000 Process Cases to Surface 14 P&L Levers for US Building Materials Manufacturer
Praxis Precision Medicines Provides Vormatrigine Program Update
UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
Vadzo Imaging Validates High-Performance Monochrome MIPI CSI-2 Camera Integration on Raspberry Pi 5
YRC Reveals: Most SOPs Are Written by Junior Staff and Ignored by Leaders New Development Framework Released
Falcone Mining LLC Announces Strategic 25-Year Mining Joint Venture in Tanzania
Thermolysis Wins Germany’s MATERIALICA Award 2025 with Innovative High-Strength Carbon Fiber Concrete
إكس أس دوت كوم تفوز بجائزة "أفضل برنامج للوسطاء المُعرِّفين" في معرض "ويلث إكسبو" بكولومبيا
175-Year-Old Mexican Family Business Cházaro Opens First Middle East Headquarters in Dubai
Orano Increases Ownership in Cigar Lake Mine in Canada
QTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related Materials
Mapi Pharma to Participate in the ASCO Annual Meeting and ADA 2026 Scientific Sessions
Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches
AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones
LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors
Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
ParaZero Secures First DefendAir Order from U.S.-Based Tier-1 Defense Corporation

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Dispatch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.